🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆
Clinical Trials in Poland / NCT06901089
Starting soon Not applicable

Hip Manipulation in Basketball Players

NCT06901089 · tracked via the Priya Life Science Poland tracker
Phase
Not applicable
Started
2025-05-10
Last updated
2025-05-09

Condition(s) studied

Manual TherapyManipulationMusclesMusculoskeletal System

Investigational drug(s) / intervention(s)

Manual therapyPlaceboExercise

Manual therapy: This technique involves a low-amplitude, high-velocity push on the hip joints with an additional two-second tension

Placebo: This technique involves a low-amplitude, high-velocity push on the shoulder and elbow joints with an additional two-second tension

Exercise: The following exercise will be performed: lunges

Study summary

Currently, it is difficult to find studies in the literature assessing the impact of manual therapy on preventing lower limb injuries in basketball players, which may later translate into improved strength and balance in athletes, when planning training or therapy programming, e.g. in patients after ankle sprains.

Eligibility

Sex
MALE
Min age
18 Years
Max age
40 Years
Healthy volunteers
Accepted
Inclusion Criteria: * healthy persons aged 18, * first league competitor, * competitor who regularly competes in the league, * expressing informed consent to participate in the study and undertakes to comply with track regulations and wear a helmet. Exclusion Criteria: * lack of volunteer consent, * previous surgeries of the upper, lower limb and spine, * other lower limb injuries in the last 6 months, * pain limiting participation in the study, * neurological diseases, * connective tissue diseases.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
OSIR przy ul. Olimpijczyków Starogardzkich 1 Starogard Gdański Poland

More Medical University of Gdansk trials in Poland

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06901089 on ClinicalTrials.gov ↗ ← All trials in Poland